Sarah Reiter - Net Worth and Insider Trading

Sarah Reiter Net Worth

The estimated net worth of Sarah Reiter is at least $403 dollars as of 2024-11-13. Sarah Reiter is the Chief Commercial Officer of Arcadia Biosciences Inc and owns about 95 shares of Arcadia Biosciences Inc (RKDA) stock worth over $403. Details can be seen in Sarah Reiter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sarah Reiter has not made any transactions after 2020-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sarah Reiter

To

Sarah Reiter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sarah Reiter owns 2 companies in total, including Arcadia Biosciences Inc (RKDA) , and Cibus Inc (CBUS) .

Click here to see the complete history of Sarah Reiter’s form 4 insider trades.

Insider Ownership Summary of Sarah Reiter

Ticker Comapny Transaction Date Type of Owner
RKDA Arcadia Biosciences Inc 2020-02-03 Chief Commercial Officer
CBUS Cibus Inc 2021-05-01 Chief Business Officer

Sarah Reiter Latest Holdings Summary

Sarah Reiter currently owns a total of 1 stock. Sarah Reiter owns 95 shares of Arcadia Biosciences Inc (RKDA) as of February 3, 2020, with a value of $403.

Latest Holdings of Sarah Reiter

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RKDA Arcadia Biosciences Inc 2020-02-03 95 4.24 403

Holding Weightings of Sarah Reiter


Sarah Reiter Form 4 Trading Tracker

According to the SEC Form 4 filings, Sarah Reiter has made a total of 3 transactions in Arcadia Biosciences Inc (RKDA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Arcadia Biosciences Inc is the acquisition of 18 shares on February 3, 2020, which cost Sarah Reiter around $1,204.

Insider Trading History of Sarah Reiter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sarah Reiter Trading Performance

GuruFocus tracks the stock performance after each of Sarah Reiter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sarah Reiter is -17.94%. GuruFocus also compares Sarah Reiter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sarah Reiter within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sarah Reiter's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sarah Reiter

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.1 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.34 LIMIT LIMIT LIMIT LIMIT LIMIT

Sarah Reiter Ownership Network

Ownership Network List of Sarah Reiter

No Data

Ownership Network Relation of Sarah Reiter

Insider Network Chart

Sarah Reiter Owned Company Details

What does Arcadia Biosciences Inc do?

Who are the key executives at Arcadia Biosciences Inc?

Sarah Reiter is the Chief Commercial Officer of Arcadia Biosciences Inc. Other key executives at Arcadia Biosciences Inc include Chief Financial Officer Thomas J. Schaefer , Chief Executive Officer Stanley Jr Jacot , and Chief Financial Officer Pamela Haley .

Arcadia Biosciences Inc (RKDA) Insider Trades Summary

Over the past 18 months, Sarah Reiter made no insider transaction in Arcadia Biosciences Inc (RKDA). Other recent insider transactions involving Arcadia Biosciences Inc (RKDA) include a net purchase of 2,049 shares made by Thomas J. Schaefer , a net purchase of 5,000 shares made by Stanley Jr Jacot , and a net purchase of 700 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Arcadia Biosciences Inc (RKDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arcadia Biosciences Inc (RKDA) were sold and 7,749 shares were bought by its insiders, resulting in a net purchase of 7,749 shares.

Arcadia Biosciences Inc (RKDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcadia Biosciences Inc Insider Transactions

No Available Data

Sarah Reiter Mailing Address

Above is the net worth, insider trading, and ownership report for Sarah Reiter. You might contact Sarah Reiter via mailing address: 202 Cousteau Place, Davis Ca 95618.